Alps Medical Breakthroughs ETF (SBIO): which funds own it
A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.
Sections with a free account
No concentrated manager holds it.
Quarter flow (concentrated managers)
Concentrated managers holding it
None in the latest quarter.
Largest holders of SBIO (all 13F filers)
- Bank of America419 KBank or trading desk+321 K
- UBS Group179 KBank or trading desk+133 K
- Wells Fargo66 KBank or trading desk+4,770
- Connors Investor Services48 KType not verified+6,933
- Morgan Stanley40 KBank or trading desk−1,762
- LPL Financial38 KWealth adviser−8,308
- Moran Wealth Management34 KWealth adviser+4,682
- Griffin Asset Management29 KType not verified−2,000
- Raymond James Financial27 KWealth adviser−27 K
- Stifel Financial26 KWealth adviser+2,519
- Shares
- 419 K
- Change
- +321 K
See more
- Type
- Bank or trading desk
- Value
- $27.1M
- Shares
- 179 K
- Change
- +133 K
See more
- Type
- Bank or trading desk
- Value
- $11.6M
- Shares
- 66 K
- Change
- +4,770
See more
- Type
- Bank or trading desk
- Value
- $4.2M
- Shares
- 48 K
- Change
- +6,933
See more
- Type
- Type not verified
- Value
- $3.1M
- Shares
- 40 K
- Change
- −1,762
See more
- Type
- Bank or trading desk
- Value
- $2.6M
- Shares
- 38 K
- Change
- −8,308
See more
- Type
- Wealth adviser
- Value
- $2.4M
- Shares
- 34 K
- Change
- +4,682
See more
- Type
- Wealth adviser
- Value
- $2.2M
- Griffin Asset Management
- Shares
- 29 K
- Change
- −2,000
See more
- Type
- Type not verified
- Value
- $1.9M
- Shares
- 27 K
- Change
- −27 K
See more
- Type
- Wealth adviser
- Value
- $1.8M
- Shares
- 26 K
- Change
- +2,519
See more
- Type
- Wealth adviser
- Value
- $1.7M
The 10 13F filers with the most shares as of Jun 30, 2026, whatever their type (index firms usually come first). “Change”: shares added or cut versus the previous quarter, split-adjusted; “no data” = there is no comparable portfolio for the previous quarter (no filing, or a filing with its holdings under confidential treatment). “% of the company” only where shares outstanding are up to date. Entities of the same group file separately and some 13F filings include other managers: there may be double counting. With a free account: the top 25, the largest buyers and the largest sellers.
This company filed no 8-K forms in the last year. Foreign companies listed in the US (ADRs) report material events on forms 6-K and 20-F, and ETFs and funds do not file 8-Ks. If it is a foreign company listed in the US through ADRs (American Depositary Receipts), what trades are bank-issued certificates that represent shares from its home market. See its filings on EDGAR ↗